Trends and outcomes of pulmonary arterial hypertension–related hospitalizations in the United States: Analysis of the nationwide inpatient sample database from 2001 through 2012

Vidhu Anand, Samit S. Roy, Stephen L. Archer, E. Kenneth Weir, Sushil Kumar Garg, Sue Duval, Thenappan Thenappan

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

IMPORTANCE: Recent trends and outcomes of pulmonary arterial hypertension (PAH)–related hospitalization in adults in the United States are unknown. OBJECTIVE: To examine the characteristics of PAH-related hospitalizations. DESIGN, SETTING, AND PARTICIPANTS: We analyzed the National Inpatient Sample database for all adult patients (≥18 years old) with PAH as the principal discharge diagnosis from January 1, 2001, through December 31, 2012. MAIN OUTCOMES AND MEASURES: We analyzed the temporal trends in hospitalization rate, hospital charges, in-hospital mortality, length of hospitalization, and comorbidities pertaining to PAH-related hospitalizations. We also evaluated the predictors of in-hospital mortality and length of hospitalizations. RESULTS: The number of PAH-related hospitalizations per year in adults decreased significantly from 2001 through 2012 (3177 vs 1345, P for trend <.001). However, the mean hospital charge per admission increased 2.7-fold from 2001 through 2012 ($29 507 vs $79 607, P for trend <.001). There was a significant increase in each of these associated comorbid conditions: diabetes (4.6%-7.8%), hypertension (5.1%-17.1%), coronary artery disease (15.6%-22.3%), chronic obstructive pulmonary disease (14.4%-20.1%), anemia (12.4%-20.4%), cardiac dysrhythmias (21.7%-29.0%), congestive heart failure (40.7%-56.1%), acute (5.9%-20.1%) or chronic kidney disease (1.1%-16.4%), fluid and electrolyte imbalance (18.9%-35.3%), pneumonia (4.4%-6.3%), cardiogenic shock (0.5%-1.5%), and acute respiratory failure (4.3%-20.8%) from 2001 through 2012. The length of hospitalization increased (mean [SE], 7.0 [0.5] days in 2001 vs 7.6 [0.6] days in 2012, P for trend = .009), but in-patient mortality remained unchanged (7.8% [1.1%] in 2001 vs 6.3% [1.7%] in 2012, P for trend = .54). Admission to a teaching hospital (β coefficient for length of hospitalization, 2.0; 95% CI, 1.3-1.6; odds ratio [OR] for mortality, 1.5; 95% CI, 1.1-2.1), cardiac dysrhythmias (β coefficient, 1.8; 95% CI, 1.1-2.6; OR, 1.8; 95% CI, 1.4-2.4), acute kidney injury (β coefficient, 5.0; 95% CI, 3.9-6.1; OR, 2.3; 95% CI, 1.7-3.2), acute cerebrovascular accident (β coefficient, 6.6; 95% CI, 1.9-11.3; OR, 6.7; 95% CI, 2.1-21.1), and acute respiratory failure (β coefficient, 6.2; 95% CI, 5.1-7.4; OR, 5.6; 95% CI, 4.2-7.5) were associated with increased length of hospitalization and in-hospital mortality. Congestive heart failure (OR, 1.7; 95% CI, 1.3-2.2), cardiogenic shock (OR, 5.4; 95% CI, 2.7-10.9), and fluid and electrolyte imbalance (OR, 1.9; 95% CI, 1.5-2.4) were associated with increased in-hospital mortality but not length of hospitalization. CONCLUSIONS AND RELEVANCE: Analyses of temporal changes in PAH care reveal a significant decrease in PAH-related hospitalizations in the United States, but hospital charges have increased substantially and are increasingly being borne by Medicare. In-hospital mortality remains unchanged, but length of hospitalization has increased. This study should help identify the characteristics of patients with PAH that are associated with increased risk of in-hospital mortality and longer length of hospitalization.

Original languageEnglish (US)
Pages (from-to)1021-1029
Number of pages9
JournalJAMA cardiology
Volume1
Issue number9
DOIs
StatePublished - Dec 2016

Bibliographical note

Funding Information:
Funding/Support: This study was supported by scientist development grant 15SDG25560048 from the American Heart Association and a High Risk and High Reward grant from the Lillehei Heart Institute (Dr Thenappan) and by a grant from the Canadian Institutes of Health Research Foundation, grants NIH-RO1-HL071115 and 1RC1HL099462 from the National Institutes of Health, Tier 1 Canada Research Chair in Mitochondrial Dynamics funding, and the William J. Henderson Foundation (Dr Archer).

Publisher Copyright:
Copyright 2016 American Medical Association. All rights reserved.

Fingerprint

Dive into the research topics of 'Trends and outcomes of pulmonary arterial hypertension–related hospitalizations in the United States: Analysis of the nationwide inpatient sample database from 2001 through 2012'. Together they form a unique fingerprint.

Cite this